Neal R. Swerdlow - Publications

Affiliations: 
University of California, San Diego, La Jolla, CA 
Area:
neuropsychiatry
Website:
http://psychiatry.ucsd.edu/swerdlow/index.html

194 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Koshiyama D, Thomas ML, Miyakoshi M, Joshi YB, Molina JL, Tanaka-Koshiyama K, Sprock J, Braff DL, Swerdlow NR, Light GA. Hierarchical Pathways from Sensory Processing to Cognitive, Clinical, and Functional Impairments in Schizophrenia. Schizophrenia Bulletin. PMID 32856089 DOI: 10.1093/Schbul/Sbaa116  0.348
2020 Koshiyama D, Miyakoshi M, Joshi YB, Molina JL, Tanaka-Koshiyama K, Sprock J, Braff DL, Swerdlow NR, Light GA. Abnormal Effective Connectivity Underlying Auditory Mismatch Negativity Impairments in Schizophrenia. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 32830097 DOI: 10.1016/J.Bpsc.2020.05.011  0.346
2020 Koshiyama D, Miyakoshi M, Joshi YB, Molina JL, Tanaka-Koshiyama K, Sprock J, Braff DL, Swerdlow NR, Light GA. A distributed frontotemporal network underlies gamma-band synchronization impairments in schizophrenia patients. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 32829382 DOI: 10.1038/S41386-020-00806-5  0.346
2020 Lee J, Green MF, Nuechterlein KH, Swerdlow NR, Greenwood TA, Hellemann GS, Lazzeroni LC, Light GA, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, et al. The effects of age and sex on cognitive impairment in schizophrenia: Findings from the Consortium on the Genetics of Schizophrenia (COGS) study. Plos One. 15: e0232855. PMID 32401791 DOI: 10.1371/Journal.Pone.0232855  0.324
2020 Molina JL, Voytek B, Thomas ML, Joshi YB, Bhakta SG, Talledo JA, Swerdlow NR, Light GA. Memantine Effects on Electroencephalographic Measures of Putative Excitatory/Inhibitory Balance in Schizophrenia. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 32340927 DOI: 10.1016/J.Bpsc.2020.02.004  0.369
2020 Young JW, Roberts BZ, Breier M, Swerdlow NR. Amphetamine improves rat 5-choice continuous performance test (5C-CPT) irrespective of concurrent low-dose haloperidol treatment. Psychopharmacology. PMID 32318751 DOI: 10.1007/S00213-020-05511-1  0.358
2020 Joshi Y, Michael T, Molina J, MacDonald L, Nungaray J, Cardoso L, Sprock J, Braff D, Green M, Nuechterlein K, Stone W, Gur R, Gur R, Swerdlow N, Light G. Impact of Anticholinergic Medication Burden on Cognition in Schizophrenia in the Consortium on the Genetics of Schizophrenia (COGS-2) Study Biological Psychiatry. 87. DOI: 10.1016/J.Biopsych.2020.02.1029  0.343
2019 Hochberger WC, Thomas ML, Joshi YB, Molina J, Treichler EBH, Nungaray J, Cardoso L, Sprock J, Swerdlow N, Light GA. Oscillatory biomarkers of early auditory information processing predict cognitive gains following targeted cognitive training in schizophrenia patients. Schizophrenia Research. PMID 31759809 DOI: 10.1016/J.Schres.2019.11.015  0.322
2019 Hochberger WC, Thomas ML, Joshi YB, Swerdlow NR, Braff DL, Gur RE, Gur RC, Light GA. Deviation from expected cognitive ability is a core cognitive feature of schizophrenia related to neurophysiologic, clinical and psychosocial functioning. Schizophrenia Research. PMID 31744751 DOI: 10.1016/J.Schres.2019.10.011  0.306
2019 Greenwood TA, Lazzeroni LC, Maihofer AX, Swerdlow NR, Calkins ME, Freedman R, Green MF, Light GA, Nievergelt CM, Nuechterlein KH, Radant AD, Siever LJ, Silverman JM, Stone WS, Sugar CA, et al. Genome-wide Association of Endophenotypes for Schizophrenia From the Consortium on the Genetics of Schizophrenia (COGS) Study. Jama Psychiatry. PMID 31596458 DOI: 10.1001/Jamapsychiatry.2019.2850  0.353
2019 Swerdlow NR, Bhakta SG, Talledo J, Benster L, Kotz J, Lavadia M, Light GA. Lessons learned by giving amphetamine to antipsychotic-medicated schizophrenia patients. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 31445502 DOI: 10.1038/S41386-019-0495-4  0.37
2019 Lainscsek C, Sampson AL, Kim R, Thomas ML, Man K, Lainscsek X, Swerdlow NR, Braff DL, Sejnowski TJ, Light GA. Nonlinear dynamics underlying sensory processing dysfunction in schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 116: 3847-3852. PMID 30808768 DOI: 10.1073/Pnas.1810572116  0.304
2018 Hochberger WC, Joshi YB, Zhang W, Thomas ML, Braff DL, Swerdlow NR, Light GA. Decomposing the constituent oscillatory dynamics underlying mismatch negativity generation in schizophrenia: Distinct relationships to clinical and cognitive functioning. International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology. PMID 30586570 DOI: 10.1016/J.Ijpsycho.2018.12.014  0.344
2018 Hochberger WC, Joshi YB, Thomas ML, Zhang W, Bismark AW, Treichler EBH, Tarasenko M, Nungaray J, Sprock J, Cardoso L, Swerdlow N, Light GA. Neurophysiologic measures of target engagement predict response to auditory-based cognitive training in treatment refractory schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 30377381 DOI: 10.1038/S41386-018-0256-9  0.326
2018 Thomas ML, Bismark AW, Joshi YB, Tarasenko M, Treichler EBH, Hochberger WC, Zhang W, Nungaray J, Sprock J, Cardoso L, Tiernan K, Attarha M, Braff DL, Vinogradov S, Swerdlow N, et al. Targeted cognitive training improves auditory and verbal outcomes among treatment refractory schizophrenia patients mandated to residential care. Schizophrenia Research. PMID 30055883 DOI: 10.1016/J.Schres.2018.07.025  0.323
2018 Kantrowitz JT, Swerdlow NR, Dunn W, Vinogradov S. Auditory System Target Engagement During Plasticity-Based Interventions in Schizophrenia: A Focus on Modulation of N-Methyl-D-Aspartate-Type Glutamate Receptor Function. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 29656951 DOI: 10.1016/j.bpsc.2018.02.002  0.335
2018 Swerdlow NR, Bhakta SG, Light GA. Room to move: Plasticity in early auditory information processing and auditory learning in schizophrenia revealed by acute pharmacological challenge. Schizophrenia Research. PMID 29627173 DOI: 10.1016/J.Schres.2018.03.037  0.336
2018 Greenwood T, Lazzeroni L, Calkins ME, Freedman R, Green MF, Gur RE, Gur RC, Light G, Nuechterlein K, Olincy A, Radant A, Seidman L, Siever L, Silverman J, Stone W, ... ... Swerdlow N, et al. S209. Genome-Wide Association of Endophenotypes for Schizophrenia From the Consortium On the Genetics of Schizophrenia (COGS) Study Biological Psychiatry. 83. DOI: 10.1016/J.Biopsych.2018.02.1101  0.336
2017 Swerdlow NR, Bhakta SG, Talledo JA, Franz DM, Hughes EL, Rana BK, Light GA. Effects of Amphetamine on Sensorimotor Gating and Neurocognition in Antipsychotic-Medicated Schizophrenia Patients. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 29154367 DOI: 10.1038/Npp.2017.285  0.391
2017 Swerdlow NR, Light GA, Thomas ML, Sprock J, Calkins ME, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Radant AD, Seidman LJ, Siever LJ, Silverman JM, et al. Deficient prepulse inhibition in schizophrenia in a multi-site cohort: Internal replication and extension. Schizophrenia Research. PMID 28549722 DOI: 10.1016/J.Schres.2017.05.013  0.352
2017 Light GA, Zhang W, Joshi YB, Bhakta S, Talledo JA, Swerdlow NR. Single-Dose Memantine Improves Cortical Oscillatory Response Dynamics in Patients with Schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 28425497 DOI: 10.1038/Npp.2017.81  0.351
2016 Thomas ML, Green MF, Hellemann G, Sugar CA, Tarasenko M, Calkins ME, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Radant AD, Seidman LJ, Shiluk AL, Siever LJ, ... ... Swerdlow NR, et al. Modeling Deficits From Early Auditory Information Processing to Psychosocial Functioning in Schizophrenia. Jama Psychiatry. PMID 27926742 DOI: 10.1001/Jamapsychiatry.2016.2980  0.342
2016 Swerdlow NR, Tarasenko M, Bhakta SG, Talledo J, Alvarez AI, Hughes EL, Rana B, Vinogradov S, Light GA. Amphetamine Enhances Gains in Auditory Discrimination Training in Adult Schizophrenia Patients. Schizophrenia Bulletin. PMID 27798224 DOI: 10.1093/Schbul/Sbw148  0.358
2016 Millard SP, Shofer J, Braff D, Calkins M, Cadenhead K, Freedman R, Green MF, Greenwood TA, Gur R, Gur R, Lazzeroni LC, Light GA, Olincy A, Nuechterlein K, Seidman L, ... ... Swerdlow NR, et al. Prioritizing schizophrenia endophenotypes for future genetic studies: An example using data from the COGS-1 family study. Schizophrenia Research. PMID 27132484 DOI: 10.1016/J.Schres.2016.04.011  0.338
2016 Powell SB, Swerdlow NR. Social Isolation Rearing and Sensorimotor Gating in Rat Models of Relevance to Schizophrenia: What We Know, and What We Do Not Know Handbook of Behavioral Neuroscience. 23: 125-138. DOI: 10.1016/B978-0-12-800981-9.00009-2  0.378
2015 Greenwood TA, Lazzeroni LC, Calkins ME, Freedman R, Green MF, Gur RE, Gur RC, Light GA, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, ... ... Swerdlow NR, et al. Genetic assessment of additional endophenotypes from the Consortium on the Genetics of Schizophrenia Family Study. Schizophrenia Research. PMID 26597662 DOI: 10.1016/J.Schres.2015.11.008  0.331
2015 Greenwood TA, Light GA, Swerdlow NR, Calkins ME, Green MF, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, et al. Gating Deficit Heritability and Correlation With Increased Clinical Severity in Schizophrenia Patients With Positive Family History. The American Journal of Psychiatry. appiajp201515050605. PMID 26441157 DOI: 10.1176/Appi.Ajp.2015.15050605  0.311
2015 Amitai N, Powell S, Weber M, Swerdlow NR, Young JW. Negative visuospatial priming in isolation-reared rats: Evidence of resistance to the disruptive effects of amphetamine. Cognitive, Affective & Behavioral Neuroscience. PMID 26220402 DOI: 10.3758/S13415-015-0369-0  0.321
2015 Swerdlow NR, Bhakta S, Chou HH, Talledo JA, Balvaneda B, Light GA. Memantine Effects on Sensorimotor Gating and Mismatch Negativity in Patients with Chronic Psychosis. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26062785 DOI: 10.1038/Npp.2015.162  0.354
2015 Nuechterlein KH, Green MF, Calkins ME, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, ... Swerdlow NR, et al. Attention/vigilance in schizophrenia: performance results from a large multi-site study of the Consortium on the Genetics of Schizophrenia (COGS). Schizophrenia Research. 163: 38-46. PMID 25749017 DOI: 10.1016/J.Schres.2015.01.017  0.36
2015 Seidman LJ, Hellemann G, Nuechterlein KH, Greenwood TA, Braff DL, Cadenhead KS, Calkins ME, Freedman R, Gur RE, Gur RC, Lazzeroni LC, Light GA, Olincy A, Radant AD, Siever LJ, ... ... Swerdlow NR, et al. Factor structure and heritability of endophenotypes in schizophrenia: findings from the Consortium on the Genetics of Schizophrenia (COGS-1). Schizophrenia Research. 163: 73-9. PMID 25682549 DOI: 10.1016/J.Schres.2015.01.027  0.344
2015 Radant AD, Millard SP, Braff DL, Calkins ME, Dobie DJ, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Meichle SP, Nuechterlein KH, Olincy A, ... ... Swerdlow NR, et al. Robust differences in antisaccade performance exist between COGS schizophrenia cases and controls regardless of recruitment strategies. Schizophrenia Research. 163: 47-52. PMID 25553977 DOI: 10.1016/J.Schres.2014.12.016  0.356
2015 Stone WS, Mesholam-Gately RI, Braff DL, Calkins ME, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Nuechterlein KH, Olincy A, Radant AD, Siever LJ, ... ... Swerdlow NR, et al. California Verbal Learning Test-II performance in schizophrenia as a function of ascertainment strategy: comparing the first and second phases of the Consortium on the Genetics of Schizophrenia (COGS). Schizophrenia Research. 163: 32-7. PMID 25497440 DOI: 10.1016/J.Schres.2014.10.029  0.31
2015 Swerdlow NR, Gur RE, Braff DL. Consortium on the Genetics of Schizophrenia (COGS) assessment of endophenotypes for schizophrenia: an introduction to this Special Issue of Schizophrenia Research. Schizophrenia Research. 163: 9-16. PMID 25454799 DOI: 10.1016/j.schres.2014.09.047  0.346
2015 Light GA, Swerdlow NR, Thomas ML, Calkins ME, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Pela M, Radant AD, Seidman LJ, Sharp RF, Siever LJ, et al. Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: characterization of demographic, clinical, cognitive, and functional correlates in COGS-2. Schizophrenia Research. 163: 63-72. PMID 25449710 DOI: 10.1016/J.Schres.2014.09.042  0.333
2015 Gur RC, Braff DL, Calkins ME, Dobie DJ, Freedman R, Green MF, Greenwood TA, Lazzeroni LC, Light GA, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, ... ... Swerdlow NR, et al. Neurocognitive performance in family-based and case-control studies of schizophrenia. Schizophrenia Research. 163: 17-23. PMID 25432636 DOI: 10.1016/J.Schres.2014.10.049  0.321
2015 Turetsky BI, Dress EM, Braff DL, Calkins ME, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, ... ... Swerdlow NR, et al. The utility of P300 as a schizophrenia endophenotype and predictive biomarker: clinical and socio-demographic modulators in COGS-2. Schizophrenia Research. 163: 53-62. PMID 25306203 DOI: 10.1016/J.Schres.2014.09.024  0.336
2015 Lee J, Green MF, Calkins ME, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Nuechterlein KH, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, ... ... Swerdlow NR, et al. Verbal working memory in schizophrenia from the Consortium on the Genetics of Schizophrenia (COGS) study: the moderating role of smoking status and antipsychotic medications. Schizophrenia Research. 163: 24-31. PMID 25248939 DOI: 10.1016/J.Schres.2014.08.014  0.334
2014 Tarasenko MA, Swerdlow NR, Makeig S, Braff DL, Light GA. The auditory brain-stem response to complex sounds: a potential biomarker for guiding treatment of psychosis. Frontiers in Psychiatry. 5: 142. PMID 25352811 DOI: 10.3389/Fpsyt.2014.00142  0.308
2014 Schmeidler J, Lazzeroni LC, Swerdlow NR, Ferreira RP, Braff DL, Calkins ME, Cadenhead KS, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Olincy A, Nuechterlein KH, et al. Paternal age of schizophrenia probands and endophenotypic differences from unaffected siblings. Psychiatry Research. 219: 67-71. PMID 24913833 DOI: 10.1016/J.Psychres.2014.05.035  0.329
2014 Light G, Greenwood TA, Swerdlow NR, Calkins ME, Freedman R, Green MF, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, et al. Comparison of the heritability of schizophrenia and endophenotypes in the COGS-1 family study. Schizophrenia Bulletin. 40: 1404-11. PMID 24903414 DOI: 10.1093/Schbul/Sbu064  0.319
2014 Tsuang D, Esterberg M, Braff D, Calkins M, Cadenhead K, Dobie D, Freedman R, Green MF, Greenwood T, Gur R, Gur R, Horan W, Lazzeroni LC, Light GA, Millard SP, ... ... Swerdlow N, et al. Is there an association between advanced paternal age and endophenotype deficit levels in schizophrenia? Plos One. 9: e88379. PMID 24523888 DOI: 10.1371/Journal.Pone.0088379  0.345
2014 Swerdlow NR, Light GA, Sprock J, Calkins ME, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Radant AD, Ray A, Seidman LJ, Siever LJ, Silverman JM, et al. Deficient prepulse inhibition in schizophrenia detected by the multi-site COGS. Schizophrenia Research. 152: 503-12. PMID 24405980 DOI: 10.1016/J.Schres.2013.12.004  0.371
2013 Swerdlow NR, Light GA, Trim RS, Breier MR, Hines SR, Powell SB. Forebrain gene expression predicts deficits in sensorimotor gating after isolation rearing in male rats. Behavioural Brain Research. 257: 118-28. PMID 24076151 DOI: 10.1016/J.Bbr.2013.09.005  0.356
2013 Gulsuner S, Walsh T, Watts AC, Lee MK, Thornton AM, Casadei S, Rippey C, Shahin H, Nimgaonkar VL, Go RC, Savage RM, Swerdlow NR, Gur RE, et al. Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network. Cell. 154: 518-29. PMID 23911319 DOI: 10.1016/J.Cell.2013.06.049  0.324
2013 Swerdlow NR, Powell SB, Breier MR, Hines SR, Light GA. Coupling of gene expression in medial prefrontal cortex and nucleus accumbens after neonatal ventral hippocampal lesions accompanies deficits in sensorimotor gating and auditory processing in rats. Neuropharmacology. 75: 38-46. PMID 23810830 DOI: 10.1016/J.Neuropharm.2013.06.003  0.39
2013 Swerdlow NR, Hines SR, Herrera SD, Weber M, Breier MR. Opposite effects of tolcapone on amphetamine-disrupted startle gating in low vs. high COMT-expressing rat strains. Pharmacology, Biochemistry, and Behavior. 106: 128-31. PMID 23567203 DOI: 10.1016/j.pbb.2013.03.015  0.394
2013 Greenwood TA, Swerdlow NR, Gur RE, Cadenhead KS, Calkins ME, Dobie DJ, Freedman R, Green MF, Gur RC, Lazzeroni LC, Nuechterlein KH, Olincy A, Radant AD, Ray A, Schork NJ, et al. Genome-wide linkage analyses of 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. The American Journal of Psychiatry. 170: 521-32. PMID 23511790 DOI: 10.1176/Appi.Ajp.2012.12020186  0.313
2013 Calkins ME, Ray A, Gur RC, Freedman R, Green MF, Greenwood TA, Light GA, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Sugar C, ... Swerdlow NR, et al. Sex differences in familiality effects on neurocognitive performance in schizophrenia. Biological Psychiatry. 73: 976-84. PMID 23395246 DOI: 10.1016/J.Biopsych.2012.12.021  0.335
2013 Chou HH, Talledo JA, Lamb SN, Thompson WK, Swerdlow NR. Amphetamine effects on MATRICS Consensus Cognitive Battery performance in healthy adults. Psychopharmacology. 227: 165-76. PMID 23314393 DOI: 10.1007/s00213-012-2948-x  0.327
2013 Amitai N, Weber M, Swerdlow NR, Sharp RF, Breier MR, Halberstadt AL, Young JW. A novel visuospatial priming task for rats with relevance to Tourette syndrome and modulation of dopamine levels. Neuroscience and Biobehavioral Reviews. 37: 1139-49. PMID 23010529 DOI: 10.1016/J.Neubiorev.2012.09.007  0.3
2012 Chou HH, Twamley E, Swerdlow NR. Towards medication-enhancement of cognitive interventions in schizophrenia. Handbook of Experimental Pharmacology. 81-111. PMID 23027413 DOI: 10.1007/978-3-642-25758-2_4  0.334
2012 Light GA, Swerdlow NR, Rissling AJ, Radant A, Sugar CA, Sprock J, Pela M, Geyer MA, Braff DL. Characterization of neurophysiologic and neurocognitive biomarkers for use in genomic and clinical outcome studies of schizophrenia. Plos One. 7: e39434. PMID 22802938 DOI: 10.1371/Journal.Pone.0039434  0.361
2012 Rissling AJ, Braff DL, Swerdlow NR, Hellemann G, Rassovsky Y, Sprock J, Pela M, Light GA. Disentangling early sensory information processing deficits in schizophrenia. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 123: 1942-9. PMID 22608970 DOI: 10.1016/J.Clinph.2012.02.079  0.373
2012 Swerdlow NR, Light GA, Breier MR, Shoemaker JM, Saint Marie RL, Neary AC, Geyer MA, Stevens KE, Powell SB. Sensory and sensorimotor gating deficits after neonatal ventral hippocampal lesions in rats. Developmental Neuroscience. 34: 240-9. PMID 22572564 DOI: 10.1159/000336841  0.4
2012 Kirihara K, Rissling AJ, Swerdlow NR, Braff DL, Light GA. Hierarchical organization of gamma and theta oscillatory dynamics in schizophrenia. Biological Psychiatry. 71: 873-80. PMID 22361076 DOI: 10.1016/J.Biopsych.2012.01.016  0.355
2012 Greenwood TA, Light GA, Swerdlow NR, Radant AD, Braff DL. Association analysis of 94 candidate genes and schizophrenia-related endophenotypes. Plos One. 7: e29630. PMID 22253750 DOI: 10.1371/Journal.Pone.0029630  0.365
2012 Chang WL, Weber M, Breier MR, Saint Marie RL, Hines SR, Swerdlow NR. Stereochemical and neuroanatomical selectivity of pramipexole effects on sensorimotor gating in rats. Brain Research. 1437: 69-76. PMID 22227455 DOI: 10.1016/J.Brainres.2011.12.007  0.547
2011 Chang WL, Breier MR, Yang A, Swerdlow NR. Disparate effects of pramipexole on locomotor activity and sensorimotor gating in Sprague-Dawley rats. Pharmacology, Biochemistry, and Behavior. 99: 634-8. PMID 21683731 DOI: 10.1016/J.Pbb.2011.06.002  0.558
2011 Greenwood TA, Lazzeroni LC, Murray SS, Cadenhead KS, Calkins ME, Dobie DJ, Green MF, Gur RE, Gur RC, Hardiman G, Kelsoe JR, Leonard S, Light GA, Nuechterlein KH, Olincy A, ... ... Swerdlow NR, et al. Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. The American Journal of Psychiatry. 168: 930-46. PMID 21498463 DOI: 10.1176/Appi.Ajp.2011.10050723  0.332
2011 Stone WS, Giuliano AJ, Tsuang MT, Braff DL, Cadenhead KS, Calkins ME, Dobie DJ, Faraone SV, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, ... ... Swerdlow NR, et al. Group and site differences on the California Verbal Learning Test in persons with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia (COGS). Schizophrenia Research. 128: 102-10. PMID 21288694 DOI: 10.1016/J.Schres.2011.01.005  0.352
2010 Chang WL, Swerdlow NR, Breier MR, Thangaraj N, Weber M. Parametric approaches towards understanding the effects of the preferential D3 receptor agonist pramipexole on prepulse inhibition in rats. Pharmacology, Biochemistry, and Behavior. 95: 473-8. PMID 20385162 DOI: 10.1016/J.Pbb.2010.04.001  0.553
2010 Olincy A, Braff DL, Adler LE, Cadenhead KS, Calkins ME, Dobie DJ, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, Nuechterlein KH, Radant AD, Schork NJ, ... ... Swerdlow NR, et al. Inhibition of the P50 cerebral evoked response to repeated auditory stimuli: results from the Consortium on Genetics of Schizophrenia. Schizophrenia Research. 119: 175-82. PMID 20382002 DOI: 10.1016/J.Schres.2010.03.004  0.365
2010 Radant AD, Dobie DJ, Calkins ME, Olincy A, Braff DL, Cadenhead KS, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Meichle SP, Millard SP, Mintz J, ... ... Swerdlow NR, et al. Antisaccade performance in schizophrenia patients, their first-degree biological relatives, and community comparison subjects: data from the COGS study. Psychophysiology. 47: 846-56. PMID 20374545 DOI: 10.1111/J.1469-8986.2010.01004.X  0.361
2010 Weber M, Chang WL, Breier MR, Yang A, Millan MJ, Swerdlow NR. The effects of the dopamine D2 agonist sumanirole on prepulse inhibition in rats. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 20: 421-5. PMID 20346635 DOI: 10.1016/J.Euroneuro.2010.02.011  0.547
2010 Saint Marie RL, Miller EJ, Breier MR, Weber M, Swerdlow NR. Projections from ventral hippocampus to medial prefrontal cortex but not nucleus accumbens remain functional after fornix lesions in rats. Neuroscience. 168: 498-504. PMID 20338222 DOI: 10.1016/j.neuroscience.2010.03.037  0.336
2010 Chang WL, Geyer MA, Buell MR, Weber M, Swerdlow NR. The effects of pramipexole on prepulse inhibition and locomotor activity in C57BL/6J mice. Behavioural Pharmacology. 21: 135-43. PMID 20215963 DOI: 10.1097/Fbp.0B013E328337Be7E  0.497
2010 Miller EJ, Saint Marie LR, Breier MR, Swerdlow NR. Pathways from the ventral hippocampus and caudal amygdala to forebrain regions that regulate sensorimotor gating in the rat. Neuroscience. 165: 601-11. PMID 19854244 DOI: 10.1016/j.neuroscience.2009.10.036  0.338
2010 Light GA, Greenwood T, Sprock J, Swerdlow N, Braff D. Use of neurophysiological biomarkers for understanding the pathways from genes to real-world daily functioning in schizophrenia Neuroscience Research. 68: e49. DOI: 10.1016/J.Neures.2010.07.463  0.319
2009 Qu Y, Saint Marie RL, Breier MR, Ko D, Stouffer D, Parsons LH, Swerdlow NR. Neural basis for a heritable phenotype: differences in the effects of apomorphine on startle gating and ventral pallidal GABA efflux in male Sprague-Dawley and Long-Evans rats. Psychopharmacology. 207: 271-80. PMID 19756524 DOI: 10.1007/S00213-009-1654-9  0.559
2009 Swerdlow NR, Lelham SA, Sutherland Owens AN, Chang WL, Sassen SD, Talledo JA. Pramipexole effects on startle gating in rats and normal men. Psychopharmacology. 205: 689-98. PMID 19506839 DOI: 10.1007/S00213-009-1577-5  0.459
2009 Weber M, Chang WL, Durbin JP, Park PE, Luedtke RR, Mach RH, Swerdlow NR. Using prepulse inhibition to detect functional D3 receptor antagonism: effects of WC10 and WC44. Pharmacology, Biochemistry, and Behavior. 93: 141-7. PMID 19426754 DOI: 10.1016/J.Pbb.2009.04.022  0.524
2009 Light G, Greenwood T, Rissling A, Pela M, Sprock J, Swerdlow N, Braff D. MMN is associated with genetic, clinical, cognitive, & functional abnormalities of schizophrenia Neuroscience Research. 65: S8. DOI: 10.1016/J.Neures.2009.09.1516  0.333
2008 Weber M, Chang WL, Breier M, Ko D, Swerdlow NR. Heritable strain differences in sensitivity to the startle gating-disruptive effects of D2 but not D3 receptor stimulation. Behavioural Pharmacology. 19: 786-95. PMID 19020413 DOI: 10.1097/Fbp.0B013E32831C3B2B  0.524
2008 Turetsky BI, Greenwood TA, Olincy A, Radant AD, Braff DL, Cadenhead KS, Dobie DJ, Freedman R, Green MF, Gur RE, Gur RC, Light GA, Mintz J, Nuechterlein KH, Schork NJ, ... ... Swerdlow NR, et al. Abnormal auditory N100 amplitude: a heritable endophenotype in first-degree relatives of schizophrenia probands. Biological Psychiatry. 64: 1051-9. PMID 18701089 DOI: 10.1016/J.Biopsych.2008.06.018  0.359
2008 Qu Y, Swerdlow NR, Weber M, Stouffer D, Parsons LH. Quinelorane, a dopamine D3/D2 receptor agonist, reduces prepulse inhibition of startle and ventral pallidal GABA efflux: time course studies. Pharmacology, Biochemistry, and Behavior. 90: 686-90. PMID 18579193 DOI: 10.1016/J.Pbb.2008.05.012  0.642
2008 Swerdlow NR, Weber M, Qu Y, Light GA, Braff DL. Realistic expectations of prepulse inhibition in translational models for schizophrenia research. Psychopharmacology. 199: 331-88. PMID 18568339 DOI: 10.1007/S00213-008-1072-4  0.375
2008 Braff DL, Greenwood TA, Swerdlow NR, Light GA, Schork NJ. Advances in endophenotyping schizophrenia. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 7: 11-8. PMID 18458787 DOI: 10.1002/J.2051-5545.2008.Tb00140.X  0.349
2008 Horan WP, Braff DL, Nuechterlein KH, Sugar CA, Cadenhead KS, Calkins ME, Dobie DJ, Freedman R, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, Olincy A, Radant AD, ... ... Swerdlow NR, et al. Verbal working memory impairments in individuals with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia. Schizophrenia Research. 103: 218-28. PMID 18406578 DOI: 10.1016/J.Schres.2008.02.014  0.352
2007 Greenwood TA, Braff DL, Light GA, Cadenhead KS, Calkins ME, Dobie DJ, Freedman R, Green MF, Gur RE, Gur RC, Mintz J, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, ... ... Swerdlow NR, et al. Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia. Archives of General Psychiatry. 64: 1242-50. PMID 17984393 DOI: 10.1001/Archpsyc.64.11.1242  0.347
2007 Harte MK, Powell SB, Swerdlow NR, Geyer MA, Reynolds GP. Deficits in parvalbumin and calbindin immunoreactive cells in the hippocampus of isolation reared rats. Journal of Neural Transmission (Vienna, Austria : 1996). 114: 893-8. PMID 17594127 DOI: 10.1007/S00702-007-0627-6  0.372
2007 Swerdlow NR, Sprock J, Light GA, Cadenhead K, Calkins ME, Dobie DJ, Freedman R, Green MF, Greenwood TA, Gur RE, Mintz J, Olincy A, Nuechterlein KH, Radant AD, Schork NJ, et al. Multi-site studies of acoustic startle and prepulse inhibition in humans: initial experience and methodological considerations based on studies by the Consortium on the Genetics of Schizophrenia. Schizophrenia Research. 92: 237-51. PMID 17346930 DOI: 10.1016/J.Schres.2007.01.012  0.327
2007 Turetsky BI, Calkins ME, Light GA, Olincy A, Radant AD, Swerdlow NR. Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures. Schizophrenia Bulletin. 33: 69-94. PMID 17135482 DOI: 10.1093/Schbul/Sbl060  0.374
2007 Calkins ME, Dobie DJ, Cadenhead KS, Olincy A, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, Nuechterlein KH, Radant AD, Schork NJ, Seidman LJ, ... ... Swerdlow NR, et al. The Consortium on the Genetics of Endophenotypes in Schizophrenia: model recruitment, assessment, and endophenotyping methods for a multisite collaboration. Schizophrenia Bulletin. 33: 33-48. PMID 17035358 DOI: 10.1093/Schbul/Sbl044  0.327
2007 Radant AD, Dobie DJ, Calkins ME, Olincy A, Braff DL, Cadenhead KS, Freedman R, Green MF, Greenwood TA, Gur RE, Light GA, Meichle SP, Mintz J, Nuechterlein KH, Schork NJ, ... ... Swerdlow NR, et al. Successful multi-site measurement of antisaccade performance deficits in schizophrenia. Schizophrenia Research. 89: 320-9. PMID 17023145 DOI: 10.1016/J.Schres.2006.08.010  0.344
2006 Swerdlow NR, Light GA, Cadenhead KS, Sprock J, Hsieh MH, Braff DL. Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function. Archives of General Psychiatry. 63: 1325-35. PMID 17146007 DOI: 10.1001/Archpsyc.63.12.1325  0.355
2006 Light GA, Hsu JL, Hsieh MH, Meyer-Gomes K, Sprock J, Swerdlow NR, Braff DL. Gamma band oscillations reveal neural network cortical coherence dysfunction in schizophrenia patients. Biological Psychiatry. 60: 1231-40. PMID 16893524 DOI: 10.1016/J.Biopsych.2006.03.055  0.348
2006 Swerdlow NR, Sprock J, Braff DL. Prepulse-elicited motor reactions do not differ between schizophrenia patients and control subjects. Behavioral Neuroscience. 120: 224-7. PMID 16492135 DOI: 10.1037/0735-7044.120.1.224  0.359
2006 Swerdlow NR, Talledo J, Sutherland AN, Nagy D, Shoemaker JM. Antipsychotic effects on prepulse inhibition in normal 'low gating' humans and rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 2011-21. PMID 16482083 DOI: 10.1038/sj.npp.1301043  0.396
2006 Swerdlow NR, Geyer MA, Shoemaker JM, Light GA, Braff DL, Stevens KE, Sharp R, Breier M, Neary A, Auerbach PP. Convergence and divergence in the neurochemical regulation of prepulse inhibition of startle and N40 suppression in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 506-15. PMID 16123772 DOI: 10.1038/Sj.Npp.1300841  0.359
2006 Swerdlow NR, Krupin AS, Bongiovanni MJ, Shoemaker JM, Goins JC, Hammer RP. Heritable differences in the dopaminergic regulation of behavior in rats: relationship to D2-like receptor G-protein function. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 721-9. PMID 16123742 DOI: 10.1038/sj.npp.1300877  0.382
2005 Braff DL, Light GA, Ellwanger J, Sprock J, Swerdlow NR. Female schizophrenia patients have prepulse inhibition deficits. Biological Psychiatry. 57: 817-20. PMID 15820241 DOI: 10.1016/J.Biopsych.2004.12.030  0.335
2005 Swerdlow NR, Kuczenski R, Goins JC, Crain SK, Ma LT, Bongiovanni MJ, Shoemaker JM. Neurochemical analysis of rat strain differences in the startle gating-disruptive effects of dopamine agonists. Pharmacology, Biochemistry, and Behavior. 80: 203-11. PMID 15680173 DOI: 10.1016/J.Pbb.2004.11.002  0.384
2005 Swerdlow NR, Stephany N, Wasserman LC, Talledo J, Sharp R, Minassian A, Auerbach PP. Intact visual latent inhibition in schizophrenia patients in a within-subject paradigm. Schizophrenia Research. 72: 169-83. PMID 15560962 DOI: 10.1016/j.schres.2004.03.022  0.374
2004 Harte MK, Powell SB, Reynolds LM, Swerdlow NR, Geyer MA, Reynolds GP. Reduced N-acetylaspartate in the temporal cortex of rats reared in isolation. Biological Psychiatry. 56: 296-9. PMID 15312819 DOI: 10.1016/J.Biopsych.2004.06.009  0.359
2003 Powell SB, Geyer MA, Preece MA, Pitcher LK, Reynolds GP, Swerdlow NR. Dopamine depletion of the nucleus accumbens reverses isolation-induced deficits in prepulse inhibition in rats. Neuroscience. 119: 233-40. PMID 12763084 DOI: 10.1016/S0306-4522(03)00122-2  0.402
2003 Swerdlow NR, Stephany N, Wasserman LC, Talledo J, Sharp R, Auerbach PP. Dopamine agonists disrupt visual latent inhibition in normal males using a within-subject paradigm. Psychopharmacology. 169: 314-20. PMID 12610717 DOI: 10.1007/s00213-002-1325-6  0.379
2003 Swerdlow NR, Platten A, Hanlon FM, Martinez ZA, Printz MP, Auerbach P. Sensitivity to sensorimotor gating-disruptive effects of apomorphine in two outbred parental rat strains and their F1 and N2 progeny. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 226-34. PMID 12589375 DOI: 10.1038/Sj.Npp.1300035  0.357
2002 Swerdlow NR, Stephany N, Shoemaker JM, Ross L, Wasserman LC, Talledo J, Auerbach PP. Effects of amantadine and bromocriptine on startle and sensorimotor gating: parametric studies and cross-species comparisons. Psychopharmacology. 164: 82-92. PMID 12373422 DOI: 10.1007/s00213-002-1172-5  0.359
2002 Powell SB, Swerdlow NR, Pitcher LK, Geyer MA. Isolation rearing-induced deficits in prepulse inhibition and locomotor habituation are not potentiated by water deprivation. Physiology & Behavior. 77: 55-64. PMID 12213502 DOI: 10.1016/S0031-9384(02)00817-X  0.359
2002 Swerdlow NR, Shoemaker JM, Stephany N, Wasserman L, Ro HJ, Geyer MA. Prestimulus effects on startle magnitude: sensory or motor? Behavioral Neuroscience. 116: 672-81. PMID 12148934 DOI: 10.1037//0735-7044.116.4.672  0.318
2002 Swerdlow NR, Eastvold A, Karban B, Ploum Y, Stephany N, Geyer MA, Cadenhead K, Auerbach PP. Dopamine agonist effects on startle and sensorimotor gating in normal male subjects: time course studies. Psychopharmacology. 161: 189-201. PMID 11981599 DOI: 10.1007/S00213-002-1040-3  0.383
2002 Martinez ZA, Platten A, Pollack E, Shoemaker J, Ro H, Pitcher L, Geyer MA, Swerdlow NR. "Typical" but not "atypical" antipsychotic effects on startle gating deficits in prepubertal rats. Psychopharmacology. 161: 38-46. PMID 11967629 DOI: 10.1007/S00213-001-0977-Y  0.415
2001 Geyer MA, Swerdlow NR. Measurement of startle response, prepulse inhibition, and habituation. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. Unit 8.7. PMID 18428548 DOI: 10.1002/0471142301.ns0807s03  0.333
2001 Braff DL, Geyer MA, Swerdlow NR. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology. 156: 234-58. PMID 11549226 DOI: 10.1007/s002130100810  0.369
2001 Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology. 156: 117-54. PMID 11549216 DOI: 10.1007/s002130100811  0.411
2001 Braff DL, Geyer MA, Light GA, Sprock J, Perry W, Cadenhead KS, Swerdlow NR. Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia. Schizophrenia Research. 49: 171-8. PMID 11343875 DOI: 10.1016/S0920-9964(00)00139-0  0.38
2000 Swerdlow NR, Braff DL, Geyer MA. Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon. Behavioural Pharmacology. 11: 185-204. PMID 11103873 DOI: 10.1097/00008877-200006000-00002  0.349
2000 Farid M, Martinez ZA, Geyer MA, Swerdlow NR. Regulation of sensorimotor gating of the startle reflex by serotonin 2A receptors. Ontogeny and strain differences. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 23: 623-32. PMID 11063918 DOI: 10.1016/S0893-133X(00)00163-9  0.379
2000 Martinez ZA, Oostwegel J, Geyer MA, Ellison GD, Swerdlow NR. "Early" and "late" effects of sustained haloperidol on apomorphine- and phencyclidine-induced sensorimotor gating deficits. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 23: 517-27. PMID 11027917 DOI: 10.1016/S0893-133X(00)00147-0  0.417
2000 Cadenhead KS, Swerdlow NR, Shafer KM, Diaz M, Braff DL. Modulation of the startle response and startle laterality in relatives of schizophrenic patients and in subjects with schizotypal personality disorder: evidence of inhibitory deficits. The American Journal of Psychiatry. 157: 1660-8. PMID 11007721 DOI: 10.1176/appi.ajp.157.10.1660  0.355
2000 Swerdlow NR, Martinez ZA, Hanlon FM, Platten A, Farid M, Auerbach P, Braff DL, Geyer MA. Toward understanding the biology of a complex phenotype: rat strain and substrain differences in the sensorimotor gating-disruptive effects of dopamine agonists. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 4325-36. PMID 10818168 DOI: 10.1523/Jneurosci.20-11-04325.2000  0.389
2000 Martinez ZA, Halim ND, Oostwegel JL, Geyer MA, Swerdlow NR. Ontogeny of phencyclidine and apomorphine-induced startle gating deficits in rats. Pharmacology, Biochemistry, and Behavior. 65: 449-57. PMID 10683485 DOI: 10.1016/S0091-3057(99)00217-8  0.429
2000 Swerdlow N, Martinez Z, Hanlon F, Auerbach P, Platten A, Braff D, Geyer M. 121. Towards the genetics of a complex phenotype: strain analyses of drug effects on startle gating Biological Psychiatry. 47: S37. DOI: 10.1016/S0006-3223(00)00383-8  0.362
2000 Martinez Z, Oostwegel J, Geyer M, Ellison G, Swerdlow N. 119. Sustained haloperidol opposes apomorphine and phencyclidine-induced startle gating deficits Biological Psychiatry. 47: S36. DOI: 10.1016/S0006-3223(00)00381-4  0.368
1999 Swerdlow NR, Braff DL, Geyer MA. Cross-species studies of sensorimotor gating of the startle reflex. Annals of the New York Academy of Sciences. 877: 202-16. PMID 10415651 DOI: 10.1111/j.1749-6632.1999.tb09269.x  0.352
1999 Geyer MA, Swerdlow NR, Lehmann-Masten V, Teschendorf HJ, Traut M, Gross G. Effects of LU-111995 in three models of disrupted prepulse inhibition in rats. The Journal of Pharmacology and Experimental Therapeutics. 290: 716-24. PMID 10411583  0.303
1999 Martinez ZA, Ellison GD, Geyer MA, Swerdlow NR. Effects of sustained phencyclidine exposure on sensorimotor gating of startle in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 21: 28-39. PMID 10379517 DOI: 10.1016/S0893-133X(98)00137-7  0.368
1999 Martinez ZA, Ellison GD, Geyer MA, Swerdlow NR. Effects of sustained cocaine exposure on sensorimotor gating of startle in rats. Psychopharmacology. 142: 253-60. PMID 10208317 DOI: 10.1007/S002130050887  0.363
1999 Braff DL, Swerdlow NR, Geyer MA. Symptom correlates of prepulse inhibition deficits in male schizophrenic patients. The American Journal of Psychiatry. 156: 596-602. PMID 10200740 DOI: 10.1176/AJP.156.4.596  0.366
1999 Cadenhead KS, Carasso BS, Swerdlow NR, Geyer MA, Braff DL. Prepulse inhibition and habituation of the startle response are stable neurobiological measures in a normal male population. Biological Psychiatry. 45: 360-4. PMID 10023514 DOI: 10.1016/S0006-3223(98)00294-7  0.357
1999 Swerdlow NR, Young AB. Neuropathology in Tourette Syndrome Cns Spectrums. 4: 65-74. DOI: 10.1017/S1092852900000833  0.307
1998 Swerdlow NR, Bakshi V, Waikar M, Taaid N, Geyer MA. Seroquel, clozapine and chlorpromazine restore sensorimotor gating in ketamine-treated rats. Psychopharmacology. 140: 75-80. PMID 9862405 DOI: 10.1007/s002130050741  0.415
1998 Swerdlow NR, Taaid N, Oostwegel JL, Randolph E, Geyer MA. Towards a cross-species pharmacology of sensorimotor gating: effects of amantadine, bromocriptine, pergolide and ropinirole on prepulse inhibition of acoustic startle in rats. Behavioural Pharmacology. 9: 389-96. PMID 9832924 DOI: 10.1097/00008877-199809000-00002  0.409
1998 Swerdlow NR, Geyer MA. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophrenia Bulletin. 24: 285-301. PMID 9613626 DOI: 10.1093/OXFORDJOURNALS.SCHBUL.A033326  0.427
1998 Bakshi VP, Swerdlow NR, Braff DL, Geyer MA. Reversal of isolation rearing-induced deficits in prepulse inhibition by Seroquel and olanzapine. Biological Psychiatry. 43: 436-45. PMID 9532349 DOI: 10.1016/S0006-3223(97)00246-1  0.405
1998 Swerdlow NR, Varty GB, Geyer MA. Discrepant findings of clozapine effects on prepulse inhibition of startle: is it the route or the rat? Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 18: 50-6. PMID 9408918 DOI: 10.1016/S0893-133X(97)00110-3  0.376
1998 Cadenhead K, Geyer M, Swerdlow N, Shafer K, Diaz M, Clementz B, Braff D. 33. Sensorimotor gating deficits in schizophrenic patients and their relatives Biological Psychiatry. 43: S10-S11. DOI: 10.1016/S0006-3223(98)90481-4  0.314
1997 Feifel D, Minor KL, Dulawa S, Swerdlow NR. The effects of intra-accumbens neurotensin on sensorimotor gating. Brain Research. 760: 80-4. PMID 9237521 DOI: 10.1016/0006-3223(96)84232-6  0.412
1997 Geyer MA, Bakshi V, Braff DL, Swerdlow NR. Developmentally specific disruptions of prepulse inhibition: Sensitivity to antipsychotics Schizophrenia Research. 24: 76-77. DOI: 10.1016/S0920-9964(97)82207-4  0.32
1997 Braff D, Swerdlow N, Perry W, Cadenhead K, Geyer M. Information processing (prepulsive inhibition) deficits in schizophrenia Biological Psychiatry. 42: 131S. DOI: 10.1016/S0006-3223(97)87437-9  0.351
1996 Wan FJ, Swerdlow NR. Sensorimotor gating in rats is regulated by different dopamine-glutamate interactions in the nucleus accumbens core and shell subregions. Brain Research. 722: 168-76. PMID 8813362 DOI: 10.1016/0006-8993(96)00209-0  0.432
1996 Swerdlow NR, Braff DL, Hartston H, Perry W, Geyer MA. Latent inhibition in schizophrenia. Schizophrenia Research. 20: 91-103. PMID 8794497 DOI: 10.1016/0920-9964(95)00097-6  0.361
1996 Swerdlow N, Bakshi V, Geyer M. Seroquel restores prepulse inhibition of startle in phencyclidine-treated rats European Neuropsychopharmacology. 6: 107. DOI: 10.1016/0924-977X(96)87794-7  0.334
1995 Bakshi VP, Geyer MA, Taaid N, Swerdlow NR. A comparison of the effects of amphetamine, strychnine and caffeine on prepulse inhibition and latent inhibition. Behavioural Pharmacology. 6: 801-809. PMID 11224383  0.317
1995 Lipska BK, Swerdlow NR, Geyer MA, Jaskiw GE, Braff DL, Weinberger DR. Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacology. 122: 35-43. PMID 8711062 DOI: 10.1007/BF02246439  0.379
1995 Swerdlow NR, Lipska BK, Weinberger DR, Braff DL, Jaskiw GE, Geyer MA. Increased sensitivity to the sensorimotor gating-disruptive effects of apomorphine after lesions of medial prefrontal cortex or ventral hippocampus in adult rats. Psychopharmacology. 122: 27-34. PMID 8711061 DOI: 10.1007/BF02246438  0.399
1995 Wan FJ, Geyer MA, Swerdlow NR. Presynaptic dopamine-glutamate interactions in the nucleus accumbens regulate sensorimotor gating. Psychopharmacology. 120: 433-41. PMID 8539324 DOI: 10.1007/BF02245815  0.406
1995 Swerdlow NR, Paulsen J, Braff DL, Butters N, Geyer MA, Swenson MR. Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 58: 192-200. PMID 7876851 DOI: 10.1136/Jnnp.58.2.192  0.328
1995 Caine SB, Geyer MA, Swerdlow NR. Effects of D3/D2 dopamine receptor agonists and antagonists on prepulse inhibition of acoustic startle in the rat. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 12: 139-45. PMID 7779242 DOI: 10.1016/0893-133X(94)00071-7  0.384
1995 Swerdlow NR, Filion D, Geyer MA, Braff DL. "Normal" personality correlates of sensorimotor, cognitive, and visuospatial gating. Biological Psychiatry. 37: 286-99. PMID 7748980 DOI: 10.1016/0006-3223(94)00138-S  0.304
1995 Braff D, Perry W, Cadenhead K, Swerdlow N, Geyer M. Prepulse inhibitory deficits in schizophrenia: Gender effects Biological Psychiatry. 37: 654. DOI: 10.1016/0006-3223(95)94629-B  0.307
1994 Swerdlow NR, Braff DL, Taaid N, Geyer MA. Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Archives of General Psychiatry. 51: 139-54. PMID 8297213 DOI: 10.1001/ARCHPSYC.1994.03950020063007  0.437
1994 Wan FJ, Geyer MA, Swerdlow NR. Accumbens D2 modulation of sensorimotor gating in rats: assessing anatomical localization. Pharmacology, Biochemistry, and Behavior. 49: 155-63. PMID 7816867 DOI: 10.1016/0091-3057(94)90470-7  0.376
1994 Swerdlow N, Lipska B, Weinberger D, Braff D, Jaskiw G, Geyer M. Startle gating after frontal cortex or hippocampal lesions in adult rats Biological Psychiatry. 35: 707. DOI: 10.1016/0006-3223(94)90987-3  0.423
1994 Lipska B, Swerdlow N, Jaskiw G, Geyer M, Braff D, Weinberger D. Neonatal hippocampal damage disrupts sensorimotor gating in postpubertal rats Biological Psychiatry. 35: 631-632. DOI: 10.1016/0006-3223(94)90719-6  0.304
1994 Bakshi V, Geyer M, Taaid N, Swerdlow N. Similar effects of stimulants on latent inhibition and prepulse inhibition Biological Psychiatry. 35: 631. DOI: 10.1016/0006-3223(94)90716-1  0.311
1994 Braff D, Filion D, Swerdlow N, Cadenhead K, Geyer M. Voluntary and involuntary attentional deficits in schizophrenia Biological Psychiatry. 35: 615. DOI: 10.1016/0006-3223(94)90659-9  0.345
1993 Swerdlow NR, Geyer MA. Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia. Pharmacology, Biochemistry, and Behavior. 44: 741-4. PMID 8451276 DOI: 10.1016/0091-3057(93)90193-W  0.435
1993 Swerdlow NR, Geyer MA. Prepulse inhibition of acoustic startle in rats after lesions of the pedunculopontine tegmental nucleus. Behavioral Neuroscience. 107: 104-17. PMID 8447948 DOI: 10.1037/0735-7044.107.1.104  0.366
1993 Swerdlow NR, Koob GF, Cador M, Lorang M, Hauger RL. Pituitary-adrenal axis responses to acute amphetamine in the rat. Pharmacology, Biochemistry, and Behavior. 45: 629-37. PMID 8392732 DOI: 10.1016/0091-3057(93)90518-X  0.473
1993 Wan FJ, Swerdlow NR. Intra-accumbens infusion of quinpirole impairs sensorimotor gating of acoustic startle in rats. Psychopharmacology. 113: 103-9. PMID 7862814 DOI: 10.1007/BF02244341  0.432
1993 Swerdlow N, Wan F, Geyer M. Nucleus accumbens D2 dopamine receptor activation impairs startle gating in rats Schizophrenia Research. 9: 253. DOI: 10.1016/0920-9964(93)90578-7  0.381
1992 Swerdlow NR, Caine SB, Braff DL, Geyer MA. The neural substrates of sensorimotor gating of the startle reflex: a review of recent findings and their implications. Journal of Psychopharmacology (Oxford, England). 6: 176-90. PMID 22291349 DOI: 10.1177/026988119200600210  0.368
1992 Swerdlow NR, Caine SB, Geyer MA. Regionally selective effects of intracerebral dopamine infusion on sensorimotor gating of the startle reflex in rats. Psychopharmacology. 108: 189-95. PMID 1410139 DOI: 10.1007/BF02245306  0.385
1991 Swerdlow NR, Caine SB, Geyer MA. Opiate-dopamine interactions in the neural substrates of acoustic startle gating in the rat. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 15: 415-26. PMID 1862221 DOI: 10.1016/0278-5846(91)90072-9  0.39
1991 Caine SB, Geyer MA, Swerdlow NR. Carbachol infusion into the dentate gyrus disrupts sensorimotor gating of startle in the rat. Psychopharmacology. 105: 347-54. PMID 1798831 DOI: 10.1007/BF02244429  0.426
1991 Koob GF, Swerdlow NR, Vaccarino F, Hubner C, Pulvirenti L, Weiss F. Functional output of the basal forebrain. Advances in Experimental Medicine and Biology. 295: 291-305. PMID 1776573 DOI: 10.1007/978-1-4757-0145-6_15  0.569
1991 Pulvirenti L, Swerdlow NR, Koob GF. Nucleus accumbens NMDA antagonist decreases locomotor activity produced by cocaine, heroin or accumbens dopamine, but not caffeine. Pharmacology, Biochemistry, and Behavior. 40: 841-5. PMID 1687766 DOI: 10.1016/0091-3057(91)90095-J  0.492
1990 Davis M, Mansbach RS, Swerdlow NR, Campeau S, Braff DL, Geyer MA. Apomorphine disrupts the inhibition of acoustic startle induced by weak prepulses in rats. Psychopharmacology. 102: 1-4. PMID 2392496 DOI: 10.1007/Bf02245735  0.321
1990 Swerdlow NR, Mansbach RS, Geyer MA, Pulvirenti L, Koob GF, Braff DL. Amphetamine disruption of prepulse inhibition of acoustic startle is reversed by depletion of mesolimbic dopamine. Psychopharmacology. 100: 413-6. PMID 2315438 DOI: 10.1007/BF02244616  0.531
1990 Geyer MA, Swerdlow NR, Mansbach RS, Braff DL. Startle response models of sensorimotor gating and habituation deficits in schizophrenia. Brain Research Bulletin. 25: 485-98. PMID 2292046 DOI: 10.1016/0361-9230(90)90241-Q  0.382
1990 Swerdlow NR, Braff DL, Geyer MA. GABAergic projection from nucleus accumbens to ventral pallidum mediates dopamine-induced sensorimotor gating deficits of acoustic startle in rats. Brain Research. 532: 146-50. PMID 2282510 DOI: 10.1016/0006-8993(90)91754-5  0.4
1990 Swerdlow NR, Braff DL, Masten VL, Geyer MA. Schizophrenic-like sensorimotor gating abnormalities in rats following dopamine infusion into the nucleus accumbens. Psychopharmacology. 101: 414-20. PMID 2114026 DOI: 10.1007/BF02244063  0.42
1990 Swerdlow NR, Koob GF. Toward a unified hypothesis of cortico-striato-pallido-thalamus function? Behavioral and Brain Sciences. 13: 172-177. DOI: 10.1017/S0140525X00078195  0.416
1989 Pulvirenti L, Swerdlow NR, Koob GF. Microinjection of a glutamate antagonist into the nucleus accumbens reduces psychostimulant locomotion in rats. Neuroscience Letters. 103: 213-8. PMID 2771183 DOI: 10.1016/0304-3940(89)90578-8  0.507
1989 Swerdlow NR, Britton KT, Koob GF. Potentiation of acoustic startle by corticotropin-releasing factor (CRF) and by fear are both reversed by alpha-helical CRF (9-41). Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 2: 285-92. PMID 2610824 DOI: 10.1016/0893-133X(89)90033-X  0.363
1989 Swerdlow NR, Koob GF. Norepinephrine stimulates behavioral activation in rats following depletion of nucleus accumbens dopamine. Pharmacology, Biochemistry, and Behavior. 33: 595-9. PMID 2511575 DOI: 10.1016/0091-3057(89)90394-8  0.526
1988 Gold LH, Swerdlow NR, Koob GF. The role of mesolimbic dopamine in conditioned locomotion produced by amphetamine. Behavioral Neuroscience. 102: 544-52. PMID 3139012 DOI: 10.1037//0735-7044.102.4.544  0.657
1988 Koob GF, Swerdlow NR. The functional output of the mesolimbic dopamine system. Annals of the New York Academy of Sciences. 537: 216-27. PMID 3059925 DOI: 10.1111/j.1749-6632.1988.tb42108.x  0.473
1987 Swerdlow NR, Koob GF. Lesions of the dorsomedial nucleus of the thalamus, medial prefrontal cortex and pedunculopontine nucleus: effects on locomotor activity mediated by nucleus accumbens-ventral pallidal circuitry. Brain Research. 412: 233-43. PMID 3607466 DOI: 10.1016/0006-8993(87)91129-2  0.493
1987 Tazi A, Swerdlow NR, LeMoal M, Rivier J, Vale W, Koob GF. Behavioral activation by CRF: evidence for the involvement of the ventral forebrain. Life Sciences. 41: 41-9. PMID 3496511 DOI: 10.1016/0024-3205(87)90554-6  0.463
1987 Swerdlow NR, Amalric M, Koob GF. Nucleus accumbens opiate-dopamine interactions and locomotor activation in the rat: evidence for a pre-synaptic locus. Pharmacology, Biochemistry, and Behavior. 26: 765-9. PMID 3110795 DOI: 10.1016/0091-3057(87)90609-5  0.514
1987 Swerdlow NR, Koob GF. Toward a unified neuropsychiatric hypothesis Behavioral and Brain Sciences. 10: 226-245. DOI: 10.1017/S0140525X00047683  0.435
1987 Swerdlow NR, Koob GF. Dopamine, schizophrenia, mania, and depression: Toward a unified hypothesis of cortico-striatopallido-thalamic function Behavioral and Brain Sciences. 10: 197-208. DOI: 10.1017/S0140525X00047488  0.503
1986 Swerdlow NR, Koob GF, Aldenhoff JB. The effects of verapamil on the locomotor-activating properties of corticotropin releasing factor (CRF) in the rat. Psychoneuroendocrinology. 11: 237-40. PMID 3489244 DOI: 10.1016/0306-4530(86)90059-4  0.465
1986 Blasco TA, Lee D, Amalric M, Swerdlow NR, Smith NT, Koob GF. The role of the nucleus raphe pontis and the caudate nucleus in alfentanil rigidity in the rat. Brain Research. 386: 280-6. PMID 3096494 DOI: 10.1016/0006-8993(86)90164-2  0.47
1986 Swerdlow NR, Geyer MA, Vale WW, Koob GF. Corticotropin-releasing factor potentiates acoustic startle in rats: blockade by chlordiazepoxide. Psychopharmacology. 88: 147-52. PMID 3081925 DOI: 10.1007/BF00652231  0.486
1986 Vaccarino FJ, Amalric M, Swerdlow NR, Koob GF. Blockade of amphetamine but not opiate-induced locomotion following antagonism of dopamine function in the rat. Pharmacology, Biochemistry, and Behavior. 24: 61-5. PMID 3080760 DOI: 10.1016/0091-3057(86)90045-6  0.501
1986 Swerdlow NR, Braff DL, Geyer MA, Koob GF. Central dopamine hyperactivity in rats mimics abnormal acoustic startle response in schizophrenics. Biological Psychiatry. 21: 23-33. PMID 3080033 DOI: 10.1016/0006-3223(86)90005-3  0.539
1986 Amalric M, Blasco TA, Smith NT, Lee DE, Swerdlow NR, Koob GF. 'Catatonia' produced by alfentanil is reversed by methylnaloxonium microinjections into the brain. Brain Research. 386: 287-95. PMID 3022882 DOI: 10.1016/0006-8993(86)90165-4  0.488
1986 Downs NS, Britton KT, Gibbs DM, Koob GF, Swerdlow NR. Supersensitive endocrine response to physostigmine in dopamine-depleted rats: a model of depression? Biological Psychiatry. 21: 775-86. PMID 3015269 DOI: 10.1016/0006-3223(86)90243-X  0.485
1986 Amalric M, Koob GF, Creese I, Swerdlow NR. "Selective" D-1 and D-2 receptor antagonists fail to differentially alter supersensitive locomotor behavior in the rat. Life Sciences. 39: 1985-93. PMID 2946915 DOI: 10.1016/0024-3205(86)90322-X  0.5
1986 Swerdlow NR, Vaccarino FJ, Amalric M, Koob GF. The neural substrates for the motor-activating properties of psychostimulants: a review of recent findings. Pharmacology, Biochemistry, and Behavior. 25: 233-48. PMID 2875470 DOI: 10.1016/0091-3057(86)90261-3  0.452
1985 Swerdlow NR, Vaccarino FJ, Koob GF. Effects of naloxone on heroin-, amphetamine- and caffeine-stimulated locomotor activity in the rat. Pharmacology, Biochemistry, and Behavior. 23: 499-501. PMID 4048244 DOI: 10.1016/0091-3057(85)90028-0  0.488
1985 Swerdlow NR, Koob GF. Separate neural substrates of the locomotor-activating properties of amphetamine, heroin, caffeine and corticotropin releasing factor (CRF) in the rat. Pharmacology, Biochemistry, and Behavior. 23: 303-7. PMID 3877311 DOI: 10.1016/0091-3057(85)90574-X  0.489
1985 Blasco TA, Lee D, Amalric M, Swerdlow NR, Smith NT, Koob GF. ALFENTANIL-INDUCED RIGIDITY IN THE RAT Anesthesiology. 63: A381. DOI: 10.1097/00000542-198509001-00381  0.464
1984 Swerdlow NR, Swanson LW, Koob GF. Substantia innominata: critical link in the behavioral expression of mesolimbic dopamine stimulation in the rat. Neuroscience Letters. 50: 19-24. PMID 6493625 DOI: 10.1016/0304-3940(84)90455-5  0.485
1984 Swerdlow NR, Koob GF. Restrained rats learn amphetamine-conditioned locomotion, but not place preference. Psychopharmacology. 84: 163-6. PMID 6438675 DOI: 10.1007/BF00427440  0.471
1984 Koob GF, Swerdlow N, Seeligson M, Eaves M, Sutton R, Rivier J, Vale W. Effects of alpha-flupenthixol and naloxone on CRF-induced locomotor activation Neuroendocrinology. 39: 450-464. PMID 6096752 DOI: 10.1159/000124021  0.48
1984 Swerdlow NR, Koob GF. The neural substrates of apomorphine-stimulated locomotor activity following denervation of the nucleus accumbens. Life Sciences. 35: 2537-44. PMID 6096659 DOI: 10.1016/0024-3205(84)90440-5  0.487
1984 Swerdlow NR, Swanson LW, Koob GF. Electrolytic lesions of the substantia innominata and lateral preoptic area attenuate the 'supersensitive' locomotor response to apomorphine resulting from denervation of the nucleus accumbens. Brain Research. 306: 141-8. PMID 6087974 DOI: 10.1016/0006-8993(84)90362-7  0.504
1983 Swerdlow NR, van der Kooy D, Koob GF, Wenger JR. Cholecystokinin produces conditioned place-aversions, not place-preferences, in food-deprived rats: evidence against involvement in satiety. Life Sciences. 32: 2087-93. PMID 6843283 DOI: 10.1016/0024-3205(83)90096-6  0.459
1983 van der Kooy D, Swerdlow NR, Koob GF. Paradoxical reinforcing properties of apomorphine: effects of nucleus accumbens and area postrema lesions. Brain Research. 259: 111-8. PMID 6824923 DOI: 10.1016/0006-8993(83)91071-5  0.494
Show low-probability matches.